Biomedcode Hellas SA offers full pharmaceutical evaluation of biological or small molecules therapeutics in humanized and mouse complex transgenic animal models of rheumatoid arthritis, cachexia, multiple organ failure, multiple sclerosis, and inflammatory bowel disease.
In addition Biomedcode offers evaluation of pharmaceuticals in experimentally induced models of inflammatory diseases such as collagen induced arthritis (CIA), Experimental Autoimmune Encephalomyelitis (EAE), LPS induced D-gal lethality models, sepsis models and others.
Biomedcode offers both macroscopic and microscopic evaluations for each model where applicable and include: 1)Histopathological analysis 2) Clinical evaluations and observations and 3) Other measurements
Biomedcode is a contract research organization (CRO).
